Kukje Pharma
국제약품 · 002720
Health Care Pharmaceuticals · KOSPI
Market cap US$54.8M (₩75.6B)
Overview
Kukje Pharma makes prescription and over-the-counter medicines, including eye drops, soft-gel capsules, and oral tablets, used by patients across South Korea.
It supplies pharmacies, clinics, hospitals, and wholesale distributors through a nationwide sales force. Listed on KOSPI, Korea's main stock exchange, the company operates its own manufacturing and research facilities in Ansan, Gyeonggi Province, and is currently running several active drug-development programmes, including research into new drugs and improved formulations of existing ones.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$98.1M
- FY2024US$113.4M
- FY2025US$127.2M
Operating profit
- FY2023−US$1.4M
- FY2024US$4.9M
- FY2025US$4.5M
Net income
- FY2023−US$6.1M
- FY2024US$3.8M
- FY2025US$4.1M
Key ratios (FY2025)
Why it matters
The company maintains its own in-house manufacturing and research site in Ansan, giving it integrated production and development capabilities under one roof.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?